tiprankstipranks
Calidi Biotherapeutics (CLDI)
NYSE MKT:CLDI
US Market
Holding CLDI?
Track your performance easily

Calidi Biotherapeutics (CLDI) Stock Investors

176 Followers
Based on 768,736 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CLDI
On average, investors allocate 0.00% of their portfolios to CLDI
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 768,736 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CLDI

6.9%
Last 7
Days
23.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CLDI, out of 768,736 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CLDI Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,685 investors who made their portfolios public
The table shows changes in CLDI in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CLDI Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Marathon Digital Holdings
5.67%
+1.72%
+5.82%
6.39B
Financial
Sirius XM Holdings
3.47%
-1.70%
-3.49%
8.54B
Communication Services
Plug Power
5.20%
-1.18%
-0.87%
1.75B
Industrials
Viking Therapeutics
4.53%
+0.19%
+7.08%
5.74B
Healthcare
Abbott Laboratories
3.55%
+0.14%
+11.41%
203.16B
Healthcare
Bristol-Myers Squibb
3.56%
-0.57%
-1.16%
118.10B
Healthcare
Caterpillar
4.40%
-1.34%
-0.49%
184.59B
Industrials
Li Auto
5.57%
-1.96%
-4.55%
23.18B
Consumer Cyclical
RTX
4.09%
-0.40%
+6.76%
158.34B
Industrials
Devon Energy
4.67%
-1.79%
+0.13%
24.90B
Energy
Based on the activity of 768,736 active portfolios
Open your Smart Portfolio

CLDI Investor Analysis

CLDI investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
20.0%
of CLDI holders
are under 35
Average Segment Performance
Average P/E Ratio29.47
Beta10.82
Dividend Yield99.38%
CLDI investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
20.0%
of CLDI holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.86
Beta20.87
Dividend Yield46.37%
CLDI investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
60.0%
of CLDI holders
are over 55
Average Segment Performance
Average P/E Ratio25.26
Beta9.51
Dividend Yield77.60%
Overview of age group and performance of CLDI stock investors
See who invests in CLDI according to age group and performance.

FAQ

How many retail Investors hold CLDI?
<0.1% of TipRanks' retail investors hold CLDI in their portfolios.
    What is CLDI Investor Sentiment?
    CLDI’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CLDI in the last 7 days?
      ▼ 6.9% of TipRanks' retail investors changed their holding of CLDI in the last 7 days.
        What percentage of retail investors changed their holding of CLDI in the last 30 days?
        ▲ 23.0% of TipRanks' retail investors changed their holding of CLDI in the last 30 days.
          What is the average age of retail investors who hold CLDI?
          The average age of CLDI Holders is over 55.
            What other stocks have CLDI investors also bought?
            CLDI Investors also bought MARA, SIRI, PLUG, VKTX, ABT, BMY, CAT, LI, RTX, DVN.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CNCCentene
              CRMDCormedix
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis